CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis - PubMed (original) (raw)
. 2009 Oct 15;114(16):3464-72.
doi: 10.1182/blood-2009-05-222273. Epub 2009 Jul 29.
Affiliations
- PMID: 19641185
- DOI: 10.1182/blood-2009-05-222273
Free article
CLEC-2 is an essential platelet-activating receptor in hemostasis and thrombosis
Frauke May et al. Blood. 2009.
Free article
Abstract
Damage to the integrity of the vessel wall leads to exposure of the subendothelial extracellular matrix (ECM), triggering platelet activation and aggregation. This process is essential for primary hemostasis but it may also lead to arterial thrombosis. Although the mechanisms underlying platelet activation on the ECM are well explored, it is less clear which receptors mediate cellular activation in a growing thrombus. Here we studied the role of the recently identified C-type lectin-like receptor 2 (CLEC-2) in this process. We show that anti-CLEC-2 antibody treatment of mice leads to complete and highly specific loss of CLEC-2 in circulating platelets for several days. CLEC-2-deficient platelets displayed normal adhesion under flow, but subsequent aggregate formation was severely defective in vitro and in vivo. As a consequence, CLEC-2 deficiency was associated with increased bleeding times and profound protection from occlusive arterial thrombus formation. These results reveal an essential function of CLEC-2 in hemostasis and thrombosis.
Comment in
- CLEC ... too!
Kunicki TJ. Kunicki TJ. Blood. 2009 Oct 15;114(16):3364-5. doi: 10.1182/blood-2009-08-236802. Blood. 2009. PMID: 19833850 No abstract available.
Similar articles
- Targeting of C-type lectin-like receptor 2 or P2Y12 for the prevention of platelet activation by immunotherapeutic CpG oligodeoxynucleotides.
Delierneux C, Donis N, Servais L, Wéra O, Lecut C, Vandereyken M, Musumeci L, Rahmouni S, Schneider J, Eble JA, Lancellotti P, Oury C. Delierneux C, et al. J Thromb Haemost. 2017 May;15(5):983-997. doi: 10.1111/jth.13669. Epub 2017 Apr 13. J Thromb Haemost. 2017. PMID: 28296036 - Vascular Smooth Muscle Cells Stimulate Platelets and Facilitate Thrombus Formation through Platelet CLEC-2: Implications in Atherothrombosis.
Inoue O, Hokamura K, Shirai T, Osada M, Tsukiji N, Hatakeyama K, Umemura K, Asada Y, Suzuki-Inoue K, Ozaki Y. Inoue O, et al. PLoS One. 2015 Sep 29;10(9):e0139357. doi: 10.1371/journal.pone.0139357. eCollection 2015. PLoS One. 2015. PMID: 26418160 Free PMC article. - C-type lectin-like receptor-2 (CLEC-2) is a key regulator of kappa-carrageenan-induced tail thrombosis model in mice.
Yokomori R, Shirai T, Tsukiji N, Oishi S, Sasaki T, Takano K, Suzuki-Inoue K. Yokomori R, et al. Platelets. 2023 Dec;34(1):2281941. doi: 10.1080/09537104.2023.2281941. Epub 2023 Nov 27. Platelets. 2023. PMID: 38010137 - Essential in vivo roles of the platelet activation receptor CLEC-2 in tumour metastasis, lymphangiogenesis and thrombus formation.
Suzuki-Inoue K. Suzuki-Inoue K. J Biochem. 2011 Aug;150(2):127-32. doi: 10.1093/jb/mvr079. Epub 2011 Jun 21. J Biochem. 2011. PMID: 21693546 Review. - Platelet CLEC-2: Roles Beyond Hemostasis.
Suzuki-Inoue K, Tsukiji N, Shirai T, Osada M, Inoue O, Ozaki Y. Suzuki-Inoue K, et al. Semin Thromb Hemost. 2018 Mar;44(2):126-134. doi: 10.1055/s-0037-1604090. Epub 2017 Oct 9. Semin Thromb Hemost. 2018. PMID: 28992650 Review.
Cited by
- Mice lacking the SLAM family member CD84 display unaltered platelet function in hemostasis and thrombosis.
Hofmann S, Braun A, Pozgaj R, Morowski M, Vögtle T, Nieswandt B. Hofmann S, et al. PLoS One. 2014 Dec 31;9(12):e115306. doi: 10.1371/journal.pone.0115306. eCollection 2014. PLoS One. 2014. PMID: 25551754 Free PMC article. - Platelets in inflammation and atherogenesis.
Nording HM, Seizer P, Langer HF. Nording HM, et al. Front Immunol. 2015 Mar 6;6:98. doi: 10.3389/fimmu.2015.00098. eCollection 2015. Front Immunol. 2015. PMID: 25798138 Free PMC article. Review. - Reduced platelet forces underlie impaired hemostasis in mouse models of _MYH9_-related disease.
Baumann J, Sachs L, Otto O, Schoen I, Nestler P, Zaninetti C, Kenny M, Kranz R, von Eysmondt H, Rodriguez J, Schäffer TE, Nagy Z, Greinacher A, Palankar R, Bender M. Baumann J, et al. Sci Adv. 2022 May 20;8(20):eabn2627. doi: 10.1126/sciadv.abn2627. Epub 2022 May 18. Sci Adv. 2022. PMID: 35584211 Free PMC article. - CLEC-2 Supports Platelet Aggregation in Mouse but not Human Blood at Arterial Shear.
Bourne JH, Smith CW, Jooss NJ, Di Y, Brown HC, Montague SJ, Thomas MR, Poulter NS, Rayes J, Watson SP. Bourne JH, et al. Thromb Haemost. 2022 Dec;122(12):1988-2000. doi: 10.1055/a-1896-6992. Epub 2022 Jul 11. Thromb Haemost. 2022. PMID: 35817083 Free PMC article. - Plasma soluble C-type lectin-like receptor-2 is associated with the risk of coronary artery disease.
Fei M, Xiang L, Chai X, Jin J, You T, Zhao Y, Ruan C, Hao Y, Zhu L. Fei M, et al. Front Med. 2020 Feb;14(1):81-90. doi: 10.1007/s11684-019-0692-x. Epub 2019 Jul 6. Front Med. 2020. PMID: 31280468
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials